Rchr
J-GLOBAL ID:202201012255680845
Update date: Aug. 08, 2022
Hasuo Hideaki
ハスオ ヒデアキ | Hasuo Hideaki
Affiliation and department:
Job title:
Professor
Research theme for competitive and other funds (10):
- 2022 - 2024 進行がん患者の筋筋膜性疼痛に対するトリガーポイント注射の有効性についての探索的多施設共同オープンラベル無作為化割付比較試験
- 2021 - 2024 がん患者の不眠障害に対する完全在宅型心拍変動バイオフィードバックシステムの開発
- 2020 - 2022 QOL計測とハートフルネス実践による食体験共創システム
- 2019 - 2022 乳がん患者へのマインドフルネスストレス低減法による介入効果の検討
- 2018 - 2022 A study of the physiological monitoring at home for sleep disturbance in patients with cancer
- 2018 - 2021 がん患者の難治性神経障害性疼痛へのエビデンスに基づく標準的薬物療法の開発
- 2019 - 2020 在宅緩和ケアにおける筋筋膜性疼痛に対する非侵襲的局所療法の有効性についての多施設無作為化比較試験
- 2018 - 2019 赤外線瞳孔計を用いた終末期がん患者のつらさの客観的評価の検討
- 2016 - 2017 進行がん患者の家族介護者の身体的健康に影響を与える因子の検討
- 2016 - 2017 在宅での心身モニタリングによるがん患者の家族セルフケアシステムの検討
Show all
Papers (35):
-
Yoshinobu Matsuda, Hideaki Hasuo, Keiichi Narita, Hiromichi Matsuoka, Ryo Morita, Daisuke Kiuchi, Tomoo Ikari, Tetsuo Hori, Koya Okazaki, Kiyohiro Sakai, et al. Relationship between dyspnoea and related factors in patients with cancer: a cross-sectional study. BMJ Supportive & Palliative Care. 2022. bmjspcare-2021
-
Tatsuo Akechi, Yosuke Kubota, Yoichi Ohtake, Noriko Setou, Maiko Fujimori, Emi Takeuchi, Akiko Kurata, Masako Okamura, Hideaki Hasuo, Ryo Sakamoto, et al. Clinical practice guidelines for the care of psychologically distressed bereaved families who have lost members to physical illness including cancer. Japanese journal of clinical oncology. 2022. 52. 6. 642-645
-
Hideaki Hasuo, Kotaro Hashimoto, Hanako Iwamoto, Naoko Miwa, Toru Kawashima, Akitoshi Oda, Go Sekimoto. Effect of ischemic compression performed by family caregivers on myofascial pain syndrome and the care burden of the families of patients: a multicenter open-label randomized comparative study. Annals of palliative medicine. 2022. 11. 4. 1179-1190
-
Hiromichi Matsuoka, Katherine Clark, Belinda Fazekas, Shunsuke Oyamada, Linda Brown, Hiroto Ishiki, Yoshinobu Matsuda, Hideaki Hasuo, Keisuke Ariyoshi, Jessica Lee, et al. Phase III, international, multicentre, double-blind, dose increment, parallel-arm, randomised controlled trial of duloxetine versus pregabalin for opioid-unresponsive neuropathic cancer pain: a JORTC-PAL16 trial protocol. BMJ open. 2022. 12. 2. e050182
-
Hideaki Hasuo, Mariko Shimazu, Ryo Sakamoto, Hisaharu Shizuma, Miki Nakura, Takakazu Oka. Relationships between alexisomia and the presence of latent trigger points in the upper trapezius of healthy volunteers. Journal of back and musculoskeletal rehabilitation. 2022. 35. 1. 67-73
more...
MISC (2):
-
Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, Takashi Kawaguchi, Keisuke Ariyoshi, Shunsuke Oyamada, Eriko Satomi, Hiroto Ishiki, Hideaki Hasuo, Hiroko Sakuma, et al. Multi-centre, randomised, double-blind, placebo-controlled trial of additive duloxetine for cancer-related neuropathic pain refractory to opioids and gabapentinoids. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY. 2018. 14. 161-162
-
Eriko Satomi, Hiromichi Matsuoka, Satoru Iwase, Tempei Miyaji, Takashi Kawaguchi, Keisuke Ariyoshi, Shunsuke Oyamada, Hideaki Hasuo, Akihiro Tokoro, Toshiaki Shinomiya, et al. A multi-center, randomized, double-blinded, placebo-controlled trial of additive effect of duloxetine for neuropathic cancer pain refractory to opioids and gabapentinoids: JORTC-PAL08 (DIRECT study). JOURNAL OF CLINICAL ONCOLOGY. 2018. 36. 15
Return to Previous Page